Aspira Women’s Health (NASDAQ:AWH) Coverage Initiated at StockNews.com

StockNews.com initiated coverage on shares of Aspira Women’s Health (NASDAQ:AWH) in a report released on Monday. The brokerage set a “hold” rating on the stock.

Aspira Women’s Health Stock Performance

AWH opened at $0.75 on Monday. The company has a market capitalization of $12.50 million, a P/E ratio of -0.62 and a beta of 1.42. The company has a 50-day moving average of $0.78 and a 200-day moving average of $0.97. Aspira Women’s Health has a 1-year low of $0.67 and a 1-year high of $5.65.

Institutional Trading of Aspira Women’s Health

A hedge fund recently raised its stake in Aspira Women’s Health stock. B. Riley Wealth Advisors Inc. increased its holdings in shares of Aspira Women’s Health Inc. (NASDAQ:AWH) by 33.8% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 316,294 shares of the company’s stock after acquiring an additional 79,898 shares during the quarter. B. Riley Wealth Advisors Inc. owned approximately 1.90% of Aspira Women’s Health worth $256,000 at the end of the most recent quarter. 12.19% of the stock is currently owned by institutional investors and hedge funds.

Aspira Women’s Health Company Profile

Aspira Women's Health Inc, together with its subsidiaries, discovers, develops, and commercializes of noninvasive AI-powered diagnostic tests for gynecologic diseases in the United States. The company's products include Ova1Plus, a qualitative serum test to assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker test intended to maintain Ova1's high sensitivity; and OvaWatch, a laboratory developed tests to assist in the initial clinical assessment of malignancy risk in all women thought to have an indeterminate or benign adnexal mass.